For patients undergoing percutaneous coronary intervention (PCI), tailoring antiplatelet therapy based on the results of platelet function testing makes no difference in the risk of recurrent ischemic ...
An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent ...
Controversy regarding a possible role of proton pump inhibitors (PPIs) in interfering with the efficacy of dual antiplatelet therapy continues with a new study showing that pantoprazole—thought to be ...
August 28, 2012 (Munich, Germany) — The debate as to whether platelet function should be routinely measured in patients undergoing PCI has been raised again with two new studies presented at the ...
Barcelona, Spain, 31 August: Studies from a growing body of convincing data show that responsiveness to antiplatelet therapy is real. This is a clinically important issue and there is a need to ...
HOUSTON--(BUSINESS WIRE)--Houston-based Aggredyne, Inc., a biomedical diagnostics company widely recognized as a leader in the field of platelet function testing, has appointed Dr. Jeffrey Dahlen as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback